App-Quantinova.ai

Feasibility, safety and efficacy of concomitant ponatinib with apixaban, as prophylaxis for arterial and venous thrombosis in patients with chronic myeloid leukaemia (CML) pre‐ and post‐allogeneic stem cell transplantation.

J. Schofield - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ponatinib

Periprocedural anticoagulation in mechanical heart valve patients – a single centre review of practice

R. Mullally - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Paediatric thrombosis: A single centre 8‐month experience

A. Abbas - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Survey of thromboprophylaxis strategies in renal transplant recipients at a single transplant unit

R. Kohli - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Heparin

Systemic Inflammation Predicts Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction

Mohamed Aboaly - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Impact of Triple Antiplatelet Therapy on Multivessel Coronary Artery Intervention in Acute Myocardial Infarction Patients

Seung Woon Rha - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

The Real World Clopidogrel and Prasugrel Effects in Japanese Acute Coronary Syndrome Patients

Kenshi Yamanaga - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Clopidogrel bisulfate

A Case of Myocardial Ischemia - Plumbing or Electrical Disorder

Subhashish Agarwal - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

eptifibatide

The Cav3.2 Transient Type Calcium Channel Regulates Platelet Activation and Arterial Thrombosis

Hem K Tamang - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Adenosine-5'-triphosphate

Repeated Social Defeat Exaggerates Fibrin-rich Clot Formation in Fecl3-induced Arterial Thrombosis Mice Model by Enhancing NETs Formation

Takeshi Sugimoto - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Fibrinogen (IV)

The "Thrombosis-Bleeding Paradox" of Mechanical Circulatory Support: Shear Stress Promotes Platelet Prothrombosis and Microparticle Generation While Inducing Integrin αIIbβ3 Shedding and Decreased Aggregability

Yana Roka-Moiia - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Phosphatidylserine

Thymidine Phosphorylase Enhances Diabetes-associated High-risk of Thrombosis

Adam M Belcher - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Diabetes is Associated With Increased Risk of Thromboembolism Independent of Type of Diabetes Treatment in Patients With Atrial Fibrillation Undergoing Coronary Angiography

Michael Maeng - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Increased Dipeptidyl Peptidase-4 Accelerates Chronic Stress-related Thrombosis in Mouse Carotid Artery Model

Xianglan Jin - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Polo-Like Kinase 3, a Mitotic Kinase is a Novel Regulator of Thrombosis

Meghna U Naik - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Endothelial LOX-1 Promotes Thrombosis Selectively In Inflammatory Condition

Akemi Kakino - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Evithrom

Regulators of G-protein Signaling 16/18 Double-knockout Mice Exhibit Enhanced Platelet Function

Ahmed B Alarabi - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Phosphatidylserine

Hemodynamic Contributions of Computer Aided Designs and Surgeon’s Unconstrained Modelling to the Fontan Operation: A Computational Fluid Dynamic Simulation Study

Yue-hin Loke - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Use of Glycoprotein IIb/IIIa Inhibition in Prevention of Blalock- Taussig Shunt Thrombosis in Pediatric Cardiac Surgery

Breanna L Piekarski - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Tirofiban hydrocloride

Innovative Online Warfarin Education is Demonstrated to be Successful for Patients Initiating Warfarin: Flying With the eKITE (electronic Kidclot Interactive Thrombosis Education) Study

Mary Bauman - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Warfarin

Filters

7277 Abstracts